Combined pharmaceutical preparation containing...

Details Combined pharmaceutical preparation containing... Combined pharmaceutical preparation containing...

2007-12-18

2007-12-18

Henley, III, Raymond J. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C514S324000

Reexamination Certificate

active

09117357

ABSTRACT:
The invention relates to a pharmaceutical combined preparation of LHRH analogues and anti-oestrogens having tissue-selective oestrogen activity and also to its use for the treatment of gynaecological disorders, especially for the treatment of endometrioses and myomas.

REFERENCES:
patent: 5395842 (1995-03-01), Labrie et al.
patent: 5451590 (1995-09-01), Dodge
patent: 5457116 (1995-10-01), Black et al.
patent: 5552417 (1996-09-01), Dodge
patent: 5593987 (1997-01-01), Cullinan et al.
patent: 5843962 (1998-12-01), Dodge
patent: 6096764 (2000-08-01), Bryant et al.
patent: 0 897 721 (1999-02-01), None
Robertson et al., Horm. Res. 1989: 32 (suppl 1):206-208.
Walker et al., Eur. J. Cancer Clin. Oncol., vol. 25, No. 4, 651-654, 1989.
Monsonego et al., Am. J. Obstet Gynecol., 1991: 164: 1181-9.
Goulding et al., Bone and Mineral, 18(2), 143-152 (1992).
Devogelaer JP et al., “LHRH analogues and bone loss”, Lancet, Jun. 27, 1987; 1(8548): 1498.

Affiliated with

Also associated with

Rating

Combined pharmaceutical preparation containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined pharmaceutical preparation containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined pharmaceutical preparation containing... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3896450